Looking to publish in Orphanet Journal of Rare Diseases? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowOrphanet Journal of Rare Diseases publishes reviews and original articles on rare diseases and orphan drugs, including translational, clinical, and epidemiological research, clinical trials of exceptional interest, and work on public health, quality of life, drug and research policies, and health economics in rare diseases. It is the official journal of Orphanet and uses section editorial boards with subject specialists across many rare disease types.
Looking to publish in Orphanet Journal of Rare Diseases? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Orphanet Journal of Rare Diseases is an invitation-only journal. Submissions are accepted by invitation from the editorial board only. The following article types are accepted:
Research
Review
Letter To The Editor
Position Statement
Recent Publications
Management of acute metabolic decompensation in maple syrup urine disease: guidance based on international clinical practice
Aude Servais, Marie Therese Abi-Wardé, Jean-Baptiste Arnoux, Alberto Burlina, Francois Feillet, Vincenzo Giordano, Nicola Longo, Sufin Yap
Correction: Recessive congenital methemoglobinemia: a systematic review of reported cases
Julie Neven, Tessi Beyltjens, Marije Meuwissen, Barbara De Bisschop, Jason Bouziotis, Machiel van den Akker
Living with Xeroderma Pigmentosum: a qualitative study of the psychosocial challenges experienced by families of children with a rare skin disorder
Jordana McLoone, Kyra Webb, Kathy Tucker, Antoinette Anazodo, Denise Wilson, Michael Rtshiladze, Linda K. Martin
Solitary infantile myofibromatosis of the extremities: a multicenter case series with descriptive analysis of recurrence and β-catenin expression
Hüseyin Emre Tepedelenli̇oğlu, Mustafa Onur Karaca, Şefik Murat Arikan, Tolga Tolunay, Güray Toğral, Tezer Kutluk
The impact of cardiovascular risk factors in non-classical Fabry disease
Bram C. F. Veldman, Laura van Dussen, Mareen R. Datema, Rutger Meinsma, Judith Jansen-Meijer, Janet Koster, André B. P. van Kuilenburg, Maud Janssens, Lourens F. H. J. Robbers, Mirjam Langeveld
Frequently asked questions
How long does it take to publish?
Submission to first decision (median): 41 days.
Reformat to Orphanet Journal of Rare Diseases using Livewrite PremiumIs a cover letter required?
A cover letter is required and should explain why the manuscript should be published in Orphanet Journal of Rare Diseases, address any issues relating to journal policies, declare potential competing interests, confirm all authors approved the submission, confirm the manuscript has not been published or submitted elsewhere, and name the special issue if applicable. Authors may also suggest preferred and non-preferred peer reviewers in the cover letter.
Reformat to Orphanet Journal of Rare Diseases using Livewrite PremiumWhat are the publication costs?
The article processing charge is £2290.00 GBP / $3090.00 USD / €2590.00 EUR per accepted article, subject to VAT or local taxes where applicable.
Reformat to Orphanet Journal of Rare Diseases using Livewrite Premium